Show simple item record

dc.contributor.authorHristova, DB
dc.contributor.authorOliveira, M
dc.contributor.authorWagner, E
dc.contributor.authorMelcher, A
dc.contributor.authorHarrington, KJ
dc.contributor.authorBelot, A
dc.contributor.authorFerguson, BJ
dc.coverage.spatialUnited States
dc.date.accessioned2024-03-13T10:39:30Z
dc.date.available2024-03-13T10:39:30Z
dc.date.issued2024-01-19
dc.identifier108760
dc.identifierS2589-0042(23)02837-7
dc.identifier.citationiScience, 2024, 27 (1), pp. 108760 -
dc.identifier.issn2589-0042
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/6187
dc.identifier.eissn2589-0042
dc.identifier.eissn2589-0042
dc.identifier.doi10.1016/j.isci.2023.108760
dc.identifier.doi10.1016/j.isci.2023.108760
dc.description.abstractTo mount an efficient interferon response to virus infection, intracellular pattern recognition receptors (PRRs) sense viral nucleic acids and activate anti-viral gene transcription. The mechanisms by which intracellular DNA and DNA viruses are sensed are relevant not only to anti-viral innate immunity, but also to autoinflammation and anti-tumour immunity through the initiation of sterile inflammation by self-DNA recognition. The PRRs that directly sense and respond to viral or damaged self-DNA function by signaling to activate interferon regulatory factor (IRF)-dependent type one interferon (IFN-I) transcription. We and others have previously defined DNA-dependent protein kinase (DNA-PK) as an essential component of the DNA-dependent anti-viral innate immune system. Here, we show that DNA-PK is essential for cyclic GMP-AMP synthase (cGAS)- and stimulator of interferon genes (STING)-dependent IFN-I responses in human cells during stimulation with exogenous DNA and infection with DNA viruses.
dc.formatElectronic-eCollection
dc.format.extent108760 -
dc.languageeng
dc.language.isoeng
dc.publisherCELL PRESS
dc.relation.ispartofiScience
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMolecular biology
dc.subjectVirology
dc.titleDNA-PKcs is required for cGAS/STING-dependent viral DNA sensing in human cells.
dc.typeJournal Article
dcterms.dateAccepted2023-12-13
dc.date.updated2024-03-13T10:23:27Z
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.isci.2023.108760
rioxxterms.licenseref.startdate2024-01-19
rioxxterms.typeJournal Article/Review
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38269102
pubs.issue1
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-groupICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-groupICR/ImmNet
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.1016/j.isci.2023.108760
pubs.volume27
icr.researchteamTargeted Therapy
dc.contributor.icrauthorHarrington, Kevin
icr.provenanceDeposited by Mr Arek Surman on 2024-03-13. Deposit type is initial. No. of files: 1. Files: 1-s2.0-S2589004223028377-main.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/